Speakers - INC2025

Abstract

Hypoxic neurological sequelae are common in newborns with birth asphyxia, oxygen is the only therapy for hypoxia/asphyxia hence Lalana Newborn resuscitation by sustained nasal oxygen inflation prevents both hypoxia and asphyxia in newborns. ‘Lalana Newborn Resuscitation’  discovered for the first time in the world is the only safest and best non-invasive resuscitation technique in newly borns transiting from fetal fluid filled lungs to well aerated neonatal lungs by continuous distending pressure with sustained nasal oxygen inflation as opposed to Intermittent Positive Pressure Ventilation (NPR) resulting in almost immediate onset of rhythmic respiration,  increased heart rate as a low heart rate indicates vagal induced bradycardia in response to perinatal asphyxia.

Methodology is assessment of all newborns by Pulse oximetry score from zero to +5 and Graded I – V based on SpO₂, respiratory and heart rate. Protocol I and Protocol II resuscitation in  term and preterm <32 weeks gestation <1250g newborns with continuous distending pressure by sustained nasal oxygen inflation removes fetal lung fluid causing uniform alveolar recruitment with large reduction in Pulmonary Vascular resistance (PVR)  facilitating reflex vital cardio-vascular changes adapting to extra-uterine life is proven both scientifically and physiologically.

Birth asphyxia continues to be a leading cause of perinatal and neonatal mortality in many Asian countries hence scientifically proven Lalana Newborn Resuscitation takes on priority in saving lives. The incidence of birth asphyxia was 21.4% among 1,383 consecutive singleton live births with peak 38.2 weeks gestation at birth in Asian - Indian newborns. Strategy defining new Ethnic Asian perinatal guidelines and Asian Due Date (ADD) at 38 +6 weeks instead of E.D.D. at 40 weeks gestation  as inherent genetic factors play a definite role in neonatal outcome and wellbeing of Asian newborns.